We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioFocus Announces Agreement with ChanTest

News   Feb 07, 2013

 
BioFocus Announces Agreement with ChanTest
 
 
 

RELATED ARTICLES

Epigenetic Drug Screens Could Unlock New Treatments for Cancer, Heart Disease and Mental Illness

News

Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images--allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental illness and more.

READ MORE

Strategy Could Help Treat Behavioral Abnormalities Linked to Autism

News

Researchers report in Nature Medicine a potential new treatment strategy for autism spectrum disorder – for which many cases are linked to mutated PTEN. Now, using Pten-deficient mice, researchers discover that a previously unexplored pathway goes “awry” in the brain, and by “rescuing” this pathway, it is possible to reverse behavioral and neurophysiological abnormalities.

READ MORE

Compound Kills Chemotherapy-resistant Cancer Cells

News

Study reports the discovery of a compound that is capable of killing chemotherapy-resistant glioblastoma-initiating cells (GICs), raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE